Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03038399 · COMPLETED
Trial details
- NCT number
- NCT03038399
- Sponsor
- ReveraGen BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2020-04-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.